This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schlesinger, L S Articles by Horwitz, M A Search for Related Content PubMed PubMed Citation Articles by Schlesinger, L S Articles by Horwitz, M A

research-article

A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.

Department of Medicine, UCLA School of Medicine 90024-1688.

ABSTRACT

We have previously determined that complement receptors on human mononuclear phagocytes and complement component C3 in nonimmune serum mediate phagocytosis of the intracellular bacterial pathogen Mycobacterium leprae, the agent of leprosy. We have also determined that C3 fixes selectively to the major surface glycolipid of M. leprae, phenolic glycolipid 1 (PGL-1). In this study, we have explored the role of natural antibody in nonimmune serum in C3 fixation and C1q binding to M. leprae and PGL-1. At serum concentrations within the range at which phagocytosis of M. leprae is maximal, C3 fixation was mediated by both the classical and the alternative complement pathways. At the low end of this serum concentration range (2.5%), C3 fixation was mediated predominantly by the classical pathway. Consistent with a role for both pathways, C3 fixation to M. leprae was enhanced by the addition of either pure C1q to C1q-depleted serum or pure factor B to factor B-depleted serum. C3 fixation to M. leprae was strictly antibody dependent regardless of the serum concentration used. C3 fixation to M. leprae occurred in nonimmune serum but not in agammaglobulinemic serum unless heat-inactivated nonimmune serum or small amounts of pure immunoglobulin G (IgG) or IgM were added. C3 fixation by both the alternative and the classical complement pathways was mediated by antibody, and the antigen-binding portion of the antibody molecule was required. C3, IgG, IgM, and C1q were readily detected on the surface of M. leprae. Consistent with the previously demonstrated exclusive role of the classical complement pathway in C3 fixation to PGL-1, C1q bound to PGL-1 in a dose-dependent fashion; C1q binding was evident in > 1.25% nonimmune serum. C1q binding to PGL-1 was strictly antibody dependent. When PGL-1 was incubated with pure C1q, little or no C1q bound to PGL-1 unless heat-inactivated nonimmune serum or pure IgG or IgM was added. When PGL-1 was incubated in nonimmune serum, C3 bound directly to PGL-1 and not to anti-PGL-1 antibody, since the amount of C3 bound to PGL-1 was not reduced by acid elution of the antibody. However, the amount of C3 bound to PGL-1 was markedly reduced by hydroxylamine treatment, providing evidence for C3 fixation via a covalent ester bond. Nonimmune serum contained antibody to all four major M. leprae surface carbohydrates. Relative to PGL-1, nonimmune serum contained more antibody to the other surface carbohydrates.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

• Balagopal, A., MacFarlane, A. S., Mohapatra, N., Soni, S., Gunn, J. S., Schlesinger, L. S. (2006). Characterization of the Receptor-Ligand Pathways Important for Entry and Survival of Francisella tularensis in Human Macrophages. Infect. Immun. 74: 5114-5125 [Abstract] [Full Text]  
• Pirofski, L.-A. (2006). Of Mice and Men, Revisited: New Insights into an Ancient Molecule from Studies of Complement Activation by Cryptococcus neoformans.. Infect. Immun. 74: 3079-3084 [Full Text]  
• Hostetter, J., Kagan, R., Steadham, E. (2005). Opsonization Effects on Mycobacterium avium subsp. paratuberculosis-Macrophage Interactions. CVI 12: 793-796 [Abstract] [Full Text]  
• Krijnen, P A J, Ciurana, C, Cramer, T, Hazes, T, Meijer, C J L M, Visser, C A, Niessen, H W M, Hack, C E (2005). IgM colocalises with complement and C reactive protein in infarcted human myocardium. J. Clin. Pathol. 58: 382-388 [Abstract] [Full Text]  
• Hilario, M. O. E., Len, C. A., Roja, S. C., Terreri, M. T., Almeida, G., Andrade, L. E. C. (2004). Frequency of Antinuclear Antibodies in Healthy Children and Adolescents. CLIN PEDIATR 43: 637-642 [Abstract]  
• Ferguson, J. S., Weis, J. J., Martin, J. L., Schlesinger, L. S. (2004). Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid. Infect. Immun. 72: 2564-2573 [Abstract] [Full Text]  
• Bohlson, S. S., Strasser, J. A., Bower, J. J., Schorey, J. S. (2001). Role of Complement in Mycobacterium avium Pathogenesis: In Vivo and In Vitro Analyses of the Host Response to Infection in the Absence of Complement Component C3. Infect. Immun. 69: 7729-7735 [Abstract] [Full Text]  
• Martin, D. W., Mohr, C. D. (2000). Invasion and Intracellular Survival of Burkholderia cepacia. Infect. Immun. 68: 24-29 [Abstract] [Full Text]  
• Glatman-Freedman, A., Casadevall, A. (1998). Serum Therapy for Tuberculosis Revisited: Reappraisal of the Role of Antibody-Mediated Immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11: 514-532 [Abstract] [Full Text]  
• Hetland, G., Wiker, H. G., Høgåsen, K., Hamasur, B., Svenson, S. B., Harboe, M. (1998). Involvement of Antilipoarabinomannan Antibodies in Classical Complement Activation in Tuberculosis. CVI 5: 211-218 [Abstract] [Full Text]  
• Zhong, Z., Pirofski, L.-a. (1998). Antifungal Activity of a Human Antiglucuronoxylomannan Antibody. CVI 5: 58-64 [Abstract] [Full Text]